NO20023041D0 - Fremgangsmåte for fremstilling av pyrazolopyridazinderivater - Google Patents

Fremgangsmåte for fremstilling av pyrazolopyridazinderivater

Info

Publication number
NO20023041D0
NO20023041D0 NO20023041A NO20023041A NO20023041D0 NO 20023041 D0 NO20023041 D0 NO 20023041D0 NO 20023041 A NO20023041 A NO 20023041A NO 20023041 A NO20023041 A NO 20023041A NO 20023041 D0 NO20023041 D0 NO 20023041D0
Authority
NO
Norway
Prior art keywords
6alkyl
6alkoxy
nsc1
fluorine atoms
substituted
Prior art date
Application number
NO20023041A
Other languages
English (en)
Other versions
NO20023041L (no
NO323412B1 (no
Inventor
Neil Mathews
Richard Anthony Ward
Andrew Jonathan Whitehead
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20023041D0 publication Critical patent/NO20023041D0/no
Publication of NO20023041L publication Critical patent/NO20023041L/no
Publication of NO323412B1 publication Critical patent/NO323412B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
NO20023041A 1999-12-22 2002-06-21 Fremgangsmate for fremstilling av pyrazolopyridazinderivater og mellomprodukter. NO323412B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9930358.8A GB9930358D0 (en) 1999-12-22 1999-12-22 Process for the preparation of chemical compounds
PCT/EP2000/013001 WO2001046194A2 (en) 1999-12-22 2000-12-20 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives

Publications (3)

Publication Number Publication Date
NO20023041D0 true NO20023041D0 (no) 2002-06-21
NO20023041L NO20023041L (no) 2002-08-16
NO323412B1 NO323412B1 (no) 2007-04-30

Family

ID=10866856

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023041A NO323412B1 (no) 1999-12-22 2002-06-21 Fremgangsmate for fremstilling av pyrazolopyridazinderivater og mellomprodukter.

Country Status (22)

Country Link
US (1) US6803463B2 (no)
EP (1) EP1242424B1 (no)
JP (1) JP2003518121A (no)
KR (1) KR20020062362A (no)
CN (1) CN1197864C (no)
AT (1) ATE299506T1 (no)
AU (1) AU776777B2 (no)
BR (1) BR0016549A (no)
CA (1) CA2395569A1 (no)
CZ (1) CZ20022178A3 (no)
DE (1) DE60021286T2 (no)
ES (1) ES2243343T3 (no)
GB (1) GB9930358D0 (no)
HK (1) HK1047586B (no)
HU (1) HUP0203407A3 (no)
IL (1) IL150274A0 (no)
MX (1) MXPA02006132A (no)
NO (1) NO323412B1 (no)
NZ (1) NZ519691A (no)
PL (1) PL356141A1 (no)
WO (1) WO2001046194A2 (no)
ZA (1) ZA200204911B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021494D0 (en) * 2000-09-01 2000-10-18 Glaxo Group Ltd Chemical comkpounds
GB0112810D0 (en) * 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
GB0112802D0 (en) * 2001-05-25 2001-07-18 Glaxo Group Ltd Pyrimidine derivatives
ATE325115T1 (de) 2002-08-19 2006-06-15 Glaxo Group Ltd Pyrimidinderivate als selektive cox-2-inhibitoren
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
GB0227443D0 (en) * 2002-11-25 2002-12-31 Glaxo Group Ltd Pyrimidine derivatives
GB0229808D0 (en) 2002-12-20 2003-01-29 Glaxo Group Ltd Novel compositions
US7145762B2 (en) * 2003-02-11 2006-12-05 Taser International, Inc. Systems and methods for immobilizing using plural energy stores
GB0319037D0 (en) * 2003-08-13 2003-09-17 Glaxo Group Ltd 7-Azaindole Derivatives
DE102006040754B3 (de) * 2006-08-31 2008-03-27 Knorr-Bremse Systeme für Nutzfahrzeuge GmbH Scheibenbremse, insbesondere für ein Nutzfahrzeug

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58134094A (ja) 1982-02-02 1983-08-10 Mitsubishi Paper Mills Ltd ３―ホルミル―ピラゾロ〔１，５―ｂ〕ピリダジン類
US5002941A (en) 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US4925849A (en) 1987-06-15 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines
US5155114A (en) 1989-01-23 1992-10-13 Fujisawa Pharmaceutical Company, Ltd. Method of treatment using pyrazolopyridine compound
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
KR920702621A (ko) 1989-06-13 1992-10-06 스튜어트 알. 슈터 단핵세포 및/또는 마크로파지에 의한 인터루킨-1 또는 종양회사인자 생성의 억제
AU622330B2 (en) 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
JPH05508153A (ja) 1990-06-12 1993-11-18 スミスクライン・ビーチャム・コーポレイション ５―リポキシゲナーゼ経路およびシクロオキシゲナーゼ経路で媒介される疾患の阻害
GB9015764D0 (en) 1990-07-18 1990-09-05 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5300478A (en) 1993-01-28 1994-04-05 Zeneca Limited Substituted fused pyrazolo compounds
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5521213A (en) 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
US5552422A (en) 1995-01-11 1996-09-03 Merck Frosst Canada, Inc. Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
CN1186492A (zh) * 1995-04-04 1998-07-01 葛兰素集团有限公司 咪唑并[1,2－α]吡啶衍生物
US6136839A (en) 1995-06-12 2000-10-24 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
US5700816A (en) 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
WO1996041645A1 (en) 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
ES2231757T3 (es) * 1997-09-05 2005-05-16 Glaxo Group Limited Composiciones farmaceutica que comprenden derivados de 2,3-diaril-pirazolo (1,5-b) piridazina.
ATE261444T1 (de) * 1999-02-27 2004-03-15 Glaxo Group Ltd Pyrazolopyridine
GB9919778D0 (en) 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
ES2243343T3 (es) 2005-12-01
HUP0203407A3 (en) 2004-12-28
WO2001046194A3 (en) 2002-05-30
CA2395569A1 (en) 2001-06-28
GB9930358D0 (en) 2000-02-09
ATE299506T1 (de) 2005-07-15
HK1047586B (zh) 2005-12-16
HK1047586A1 (en) 2003-02-28
EP1242424A2 (en) 2002-09-25
CN1197864C (zh) 2005-04-20
AU776777B2 (en) 2004-09-23
KR20020062362A (ko) 2002-07-25
NZ519691A (en) 2004-06-25
US20030078267A1 (en) 2003-04-24
WO2001046194A2 (en) 2001-06-28
DE60021286T2 (de) 2005-12-29
NO20023041L (no) 2002-08-16
US6803463B2 (en) 2004-10-12
EP1242424B1 (en) 2005-07-13
AU2675101A (en) 2001-07-03
CZ20022178A3 (cs) 2003-02-12
ZA200204911B (en) 2004-02-13
HUP0203407A2 (hu) 2003-01-28
BR0016549A (pt) 2002-09-17
JP2003518121A (ja) 2003-06-03
IL150274A0 (en) 2002-12-01
DE60021286D1 (de) 2005-08-18
NO323412B1 (no) 2007-04-30
MXPA02006132A (es) 2002-12-05
PL356141A1 (en) 2004-06-14
CN1413215A (zh) 2003-04-23

Similar Documents

Publication Publication Date Title
YU11900A (sh) Derivati 2,3-diaril-pirazolo (1,5-b) piridazina, njihovo dobijanje i njihova upotreba kao inhibitora ciklooksigenaze 2(cox-2)
TR200101208T2 (tr) Seçici COX-2 inhibitörleri olarak pirazolopiridin türevleri
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
AU2661400A (en) Pyrazolopyridines
AU2002211216A1 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
AP2002002535A0 (en) Caspase inhibitors and uses thereof.
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
CA2244139A1 (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
NO20023041D0 (no) Fremgangsmåte for fremstilling av pyrazolopyridazinderivater
MY118004A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
AU3415599A (en) Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
MY138826A (en) 2,7-substituted indoles
ATE272617T1 (de) Sulfonamid-derivate
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
EP0806413A4 (en) 2-SUBSTITUTED VITAMIN D3 DERIVATIVES
DE69330601D1 (de) Serotoninergische ergolin derivate
AU2001259242A1 (en) Process for the preparation of chemical compounds
AU5125798A (en) Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
CA2009542A1 (en) Cyclic guanidines as calcium antagonists
MY117739A (en) Chemical compounds
TW288015B (en) New chromene derivatives